Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab‐induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis
Fabio S. Ryser, Ayla Yalamanoglu, Alan Valaperti, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2712-2723
Open Access | Times Cited: 18

Showing 18 citing articles:

Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 21
Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
Patrick Huber, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 3108-3117
Open Access | Times Cited: 6
Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis
Xiaoying Chen, Haopeng Zhi, Xiaohu Wang, et al.
Lung (2024) Vol. 202, Iss. 4, pp. 367-383
Closed Access | Times Cited: 5
The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4
Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Andrea Ciofalo, Antonella Loperfido, Silvia Baroncelli, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Closed Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Once upon a time: the curious case of a backward story of EGPA
Diego Bagnasco, Benedetta Bondi, Veronica Capuano, et al.
(2025) Vol. 3
Closed Access
Genetic and Epigenetic Interconnections Between Atopic Dermatitis, Allergic Rhinitis, and Rhinitis with Nasal Polyps
Alexandra Danielidi, Spyridon Lygeros, A. Anastogianni, et al.
Allergies (2025) Vol. 5, Iss. 2, pp. 9-9
Open Access
Chronic Rhinosinusitis: A Narrative Review of Predisposing Factors and Their Relationships with Endotypes
Song Luo, Zhiling Zhu, Song Li
Allergy medicine. (2025), pp. 100050-100050
Open Access
Long-term efficacy and safety of dupilumab for severe bullous pemphigoid: A prospective cohort study
Dawei Huang, Yuexin Zhang, Yingyuan Yu, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111157-111157
Open Access | Times Cited: 10
Polyps’ Extension and Recurrence in Different Endotypes of Chronic Rhinosinusitis: A Series of 449 Consecutive Patients
Leonardo Calvanese, Cristoforo Fabbris, Giuseppe Brescia, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1125-1125
Open Access | Times Cited: 2
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
Eugenio De Corso, Claudio Montuori, Silvia Baroni, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 5, pp. 2429-2440
Closed Access | Times Cited: 6
Regression of metastatic malignant melanoma with dupilumab: A case report
John Herbert Marr, Abbas Al‐Shammari
Skin Health and Disease (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 1
Identification and validation of autophagy-related genes and exploration of their relationship with disease severity in chronic rhinosinusitis with nasal polyps
Jiajia Zi, Longgang Yu, Lin Wang, et al.
Asia Pacific Allergy (2024) Vol. 14, Iss. 4, pp. 162-173
Open Access | Times Cited: 1
Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps
Michael Habenbacher, Ulrich Moser, Ahmed Abaira, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1370-1370
Open Access | Times Cited: 1
Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics
Anna Sophie Hoffmann, Christian Betz, Robert Böscke, et al.
HNO (2024) Vol. 72, Iss. 4, pp. 225-230
Closed Access
Non-invasive strategy: Developing a topical IL-4Rα-specific nanobody for the treatment of allergic airway diseases
Taeyoung Ahn, Dong Hyuk Lee, Geun-Ah Kim, et al.
Materials Today Bio (2024) Vol. 27, pp. 101148-101148
Open Access
Page 1

Scroll to top